Richard A. Steinman, M.D., Ph.D. 
Associate Professor of Medicine and Pharmacology

University of Pittsburgh Cancer Institute
The Hillman Cancer Center
Research Pavilion, Suite 2.18
5117 Centre Avenue
Pittsburgh, PA 15213-1863


Office: 412-623-3237
Lab: 412-623-3221
Fax: 412-623-7768
Email:  steinman@pitt.edu

 

 

 

Welcome to the Steinman Lab Home Page

Home Publications Research Details Training Opportunities People  

 

 

 

                    

 


Research Overview:

Our laboratory studies cancer and cellular differentiation. Basic questions which we are addressing include: Why do hematopoietic stem cells remain quiescent for long periods of time? We are characterizing and dissecting molecular controls of this phenomenon. These studies will shed light on the regulation of cell numbers in the blood both in cancer and during normal development.  Another question is what coordinates the exit from the cell cycle as blood cells undergo terminal differentiation. We are using structure-function mutations and tandem affinity purification techniques to examine how cdk-inhibitors and regulatory proteins such as C/EBP isoforms choreograph these transitions. This work should help to clarify how normal differentiation is blocked in leukemias. We are using direct protein transduction techniques to modulate pathways involving cdk-inhibitors both in leukemias and other cancers.  Another question which we are studying is why cancer cells grow past confluence?  Our approach to this question examines the response of STAT signaling pathways to cell confluence.

Goals outside the laboratory include optimizing knowledge and understanding of cancer in the community.  Projects have included development of a trading card game teaching about cancer and research examining ways to make health websites more accessible to low-literacy individuals.  A collaboration with Hampton University, a highly-respected minority-training institution, seeks to develop a cancer curriculum at Hampton.

Recent Publications:

Steinman RA, A Wentzel, Y Lu, C Stehle, JR Grandis.  Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2.  Oncogene, in press (2003).  Abstract  Pdf

Steinman RA, Blastos MT.  A trading-card game teaching about host defence. Med Educ. 2002 Dec;36(12):1201-8.  Abstract  Pdf

Kharbanda S, Salter RD, Dong X, Tuma-Warrino RJ, Steinman RA.  BDCM: a novel B-cell line with genetic and functional similarity to dendritic cells.  Br J Haematol. 2002 Dec;119(3):819-25.  Abstract Pdf

Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S, Grandis JR.  STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.  Cell Growth Differ. 2002 Aug;13(8):355-62. Abstract

Sharifi, N and Steinman, RA. Targeted Chemotherapy: Chronic Myelogenous Leukemia as a Model, Journal of Molecular Medicine, 80: 219-232 (2002). Abstract Pdf

Steinman, RA. Cell cycle regulators in hematopoiesis, Oncogene, 21: 3403-3414 (2002).  Abstract Pdf

B. Yaroslavskiy, S. Watkins, D. Stolz, N. Bradbury, S. Alba and R. A. Steinman.  p27kip1 localizes to detergent-insoluble microdomains within lymphocyte membranes.  Molecular Medicine, 7, 49-58 (2001).  Abstract Pdf

R. A. Steinman, C. Stehle and Y. Lu.  Cell cycle-independent upregulation of p27KIP1 by p21WAF1 in K562 cells.  Oncogene, 20, 6524-6530 (2001).  Abstract Pdf

B. Yaroslavskiy, S. Watkins and R. A. Steinman. Dynamic changes in p27kip1 variant expression in activated lymphocytes. J. Cell. Biochem. 83, 380-390 (2001).  Abstract Pdf


Click for Cancer Genetics article: